BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/16/2019 12:17:24 PM | Browse: 34 | Download: 28
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 46481
Country of Manuscript Source United States
Received
2019-02-26 06:58
Peer-Review Started
2019-02-27 12:53
To Make the First Decision
2019-08-01 00:14
Return for Revision
2019-08-21 03:34
Revised
2019-09-03 04:17
Second Decision
2019-09-12 09:59
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-09-12 16:39
Articles in Press
2019-09-12 16:39
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-09-23 06:26
Publish the Manuscript Online
2019-10-16 12:17
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Oncology
Manuscript Type Retrospective Study
Article Title Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism
Manuscript Source Unsolicited Manuscript
All Author List Alejandro Recio-Boiles, Sumana Veeravelli, Jessica Vondrak, Hani M Babiker, Aaron J Scott, Rachna T Shroff, Hitendra Patel, Emad Elquza and Ali McBride
ORCID
Author(s) ORCID Number
Alejandro Recio-Boiles http://orcid.org/0000-0002-5423-3112
Sumana Veeravelli http://orcid.org/0000-0002-7179-6996
Jessica Vondrak http://orcid.org/0000-0001-7570-8538
Hani M Babiker http://orcid.org/0000-0002-9368-6296
Aaron J Scott http://orcid.org/0000-0002-0301-3072
Rachna T Shroff http://orcid.org/0000-0003-0066-2672
Hitendra Patel http://orcid.org/0000-0001-8746-2600
Emad Elquza http://orcid.org/0000-0003-3383-7950
Ali McBride http://orcid.org/0000-0002-9430-4675
Funding Agency and Grant Number
Corresponding author Alejandro Recio-Boiles, MD, Academic Fellow, Hematology and Medical Oncology Fellow, Assistant Professor of Medicine, Department of Medicine, Hematology and Medical Oncology, University of Arizona Cancer Center, 1515 N Campbell Ave, Tucson, AZ85724, United States. areciomd@email.arizona.edu
Keywords Direct oral anticoagulants; Low molecular weight heparin; Gastrointestinal cancer; Venous thromboembolism; Cancer associated thrombosis; Clinical risk
Core Tip Our study shows similar efficacy of low molecular weight heparin as compared to apixaban and rivaroxaban. However, side effect profiles of these new direct oral anticoagulants (DOAC)’s may lead to a preferred use of apixaban, which had lower bleeding events in the highly sensitive gastrointestinal cancer (GICA) patient population. GICA-venous thromboembolism (VTE) is a high-risk patient subpopulation and warrants additional dedicated prospective clinical analysis of the efficacy and safety of DOACs. In addition, evaluation of clinical predictors that may influence the risk of VTE recurrence and major bleeding should include GICA as a high-risk group.
Publish Date 2019-10-16 12:17
Citation Recio-Boiles A, Veeravelli S, Vondrak J, Babiker HM, Scott AJ, Shroff RT, Patel H, Elquza E, Ali McBride A. Evaluation of the safety and effectiveness of direct oral anticoagulants and low molecular weight heparin in gastrointestinal cancer-associated venous thromboembolism. World J Gastrointest Oncol 2019; 11(10): 866-876
Url https://www.wjgnet.com/1948-5204/full/v11/i10/866.htm
DOI https://dx.doi.org/10.4251/wjgo.v11.i10.866
Full Article (PDF) WJGO-11-866.pdf
Full Article (Word) WJGO-11-866.docx
Manuscript File 46481-Review.docx
Answering Reviewers 46481-Answering reviewers.pdf
Audio Core Tip 46481-Audio core tip.mp3
Biostatistics Review Certificate 46481-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 46481-Conflict-of-interest statement.pdf
Copyright License Agreement 46481-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s) 46481-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 46481-Institutional review board statement.pdf
Supplementary Material 46481-Supplementary material.pdf
Peer-review Report 46481-Peer-review(s).pdf
Scientific Misconduct Check 46481-Scientific misconduct check.pdf
Scientific Editor Work List 46481-Scientific editor work list.pdf